Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2017 Mar 21;10:1709. doi: 10.2147/OTT.S135456

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]

PMCID: PMC5367900  PMID: 28356758

Xu J, Liu X, Yang S, Zhang X, Shi Y. OncoTargets and Therapy. 2016;9:2911–2917.

On page 2911, the affiliation was listed as Department of Internal Medicine, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China. It should have been Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China.


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES